Cytiva is a global provider of technologies and services that help advance and accelerate the development and manufacture of therapeutics. Previously GE Healthcare Life Sciences, Cytiva’s diverse portfolio includes well-recognized brands such as ÄKTA, Amersham, Biacore, FlexFactory, HyClone, MabSelect, Sefia, Whatman, Xcellerex and Xuri. Cytiva brings speed, efficiency, and capacity to research and manufacturing workflows, enabling the delivery of transformative medicines to patients. Visit cytiva.com for more.
Visualize Upstream and Downstream Process Intensification Strategies with New Process Intensifier App
Process intensification is an integral part of process design in biomanufacturing . This heightened awareness is due to the increased diversity and complexity of biomolecules and growing pressure to increase the productivity, flexibility and throughput ... Continued
mRNA therapy is a growing field that is experiencing rapid development and expansion. There are many applications in development that are too numerous to detail in this brief report. The technology offers great benefit and potentials for infectious diseases and personalized medicines due to its advantages in flexibility, cost and speed of development. There are of course still challenges to overcome to fully realize the potential of this technology including lack of experience and knowledge of scaling up mRNA processes, perceived regulatory uncertainties and targeted delivery technologies. The COVID-19 pandemic publicly demonstrated the promise of mRNA therapies, and the future looks bright for this emerging industry....Continued
How cell culture process variability can be controlled using supplier enabled data management and analytics. Implementing digital biomanufacturing to better control and analyze raw material to reduce variability....Continued